News tagged with oxaliplatin
Balancing oxaliplatin dose with neurological side effects in metastatic colon cancer
The drug oxaliplatin is a major reason the prognosis for metastatic colon cancer has gone from an expected survival of several months to a couple years. Unfortunately, the drug can also carry with it debilitating neurological ...
Feb 02, 2012 |
5 / 5 (1) |
0
Study showed oxaliplatin improved colon cancer patient survival
Stage III colon cancer patients in the general population who receive adjuvant treatment for the disease have an improved rate of survival when oxaliplatin is added to 5-fluorouracil (5FU), according to a study published ...
Jan 20, 2012 |
not rated yet |
0
Popular colorectal cancer drug may cause permanent nerve damage
(Medical Xpress) -- Oxaliplatin, a platinum-based anticancer drug that’s made enormous headway in recent years against colorectal cancer, appears to cause nerve damage that may be permanent and worsens even months after ...
Medicine & Health / Neuroscience
Sep 28, 2011 |
5 / 5 (1) |
0
|
Chemo plus radiation before surgery increases tumor response for rectal cancer
Rectal cancer patients who use a new combination of the chemotherapy, Capecitabine, together with five weeks of radiation (50 Gy) before surgery have an 88 percent chance of surviving the cancer three years after treatment, ...
Sep 26, 2011 |
not rated yet |
0
Scientist proves potential of new nanoparticle design for cancer therapy
A new type of nanoparticle developed in the laboratories at the University of North Carolina has shown potential for more effective delivery of chemotherapy to treat cancer. Wenbin Lin, PhD, Kenan Distinguished Professor ...
Nanotechnology / Bio & Medicine
Sep 20, 2011 |
5 / 5 (2) |
0
Soy peptide + chemo drug block colon cancer's spread to liver
A University of Illinois study reports a promising new weapon in treating metastatic colon cancer, particularly in patients who have developed resistance to chemotherapy.
Sep 19, 2011 |
3 / 5 (2) |
0
|
GOLFIG increased progression-free survival in colorectal cancer patients
Oncologists can use colorectal cancer patients' own immune system to boost the effects of chemotherapy and increase progression-free survival, according to Phase III study results presented at the AACR 102nd Annual Meeting ...
Apr 06, 2011 |
not rated yet |
0
Making hypersensitivity to cold a thing of the past in colorectal cancer treatment
Putting gloves on before opening the fridge. Avoiding the refrigerated section in supermarkets. This is routine for almost all colorectal cancer patients receiving chemotherapy with oxaliplatin, which causes hypersensitivity ...
Apr 04, 2011 |
not rated yet |
0
Researchers discover genes affecting cancer drug
Genomic research could help doctors better target a drug widely used to treat colorectal cancer patients, according to a study by Genomic Health Inc. and the Translational Genomics Research Institute (TGen).
Jan 13, 2011 |
not rated yet |
0
Cetuximab did not add significant benefit to NORDIC FLOX regimen in first line treatment of mCRC
Adding the targeted drug cetuximab to a three-drug chemotherapy regimen for first-line treatment of metastatic colorectal cancer does not improve response rate, progression-free survival or overall survival, researchers reported ...
Oct 12, 2010 |
4 / 5 (1) |
0
Pancreatic cancer: Researchers find drug that reverses resistance to chemotherapy
For the first time researchers have shown that by inhibiting the action of an enzyme called TAK-1, it is possible to make pancreatic cancer cells sensitive to chemotherapy, opening the way for the development of a new drug ...
Sep 24, 2009 |
4 / 5 (1) |
0
New treatments offer better survival and fresh challenges in colorectal cancer
Colorectal cancer (CRC) is the second leading cause of cancer-related death in the Western world. Fortunately physicians today have an abundance of drug therapies available to improve survival length for more advanced cancer ...
Aug 21, 2009 |
not rated yet |
0
Costly cancer drugs are worth it, study finds
(PhysOrg.com) -- The cost for chemotherapy medications to treat colorectal cancer for six months has jumped 2,600 percent from 1993 to 2005. But such rising costs are worth the price, asserts a new report from Cornell, when ...
Aug 14, 2009 |
2.5 / 5 (2) |
2
Chemotherapy combination outcomes differ for aged, younger colon cancer patients
ORLANDO, Fla.--The combination of chemotherapies 5FU and oxaliplatin compared to 5FU alone after surgery for colon cancer decreases colon cancer recurrence and promotes longer survival for patients under 70 -- but not for ...
May 29, 2009 |
5 / 5 (1) |
0
A safe, well-tolerated, and effective treatment for metastatic esophageal cancer
Metastatic esophageal squamous cell cancer has very poor prognosis. Conventional surgery is considered the most effective treatment, but many cases are inoperable at the time of diagnosis.
Feb 23, 2009 |
5 / 5 (1) |
0
- Pages: 1
Oxaliplatin
Oxaliplatin is a coordination complex that is used in cancer chemotherapy. These platinum-based drugs are usually classified as alkylating agents, although they are not actually alkylating groups (they function by a similar mechanism).
For more information about Oxaliplatin, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
